Is the AI Revolution Built on a House of Cards?In the treacherous landscape of technological ambition, Nvidia emerges as a cautionary tale of unchecked corporate hubris and potentially unsustainable growth. What appeared to be an unstoppable technological juggernaut now reveals deep fissures in its seemingly impenetrable facade, with mounting challenges threatening to unravel its carefully constructed narrative of AI dominance. Specific challenges underscore this fragility: comments from Microsoft's Satya Nadella suggest a potential moderation in AI chip demand, while Alphabet's Sundar Pichai has highlighted that "the low-hanging fruit is gone" in AI model development.
Beneath the glossy veneer of technological innovation lies a troubling reality of regulatory scrutiny and market volatility. Nvidia faces a perfect storm of challenges: a potential slowdown in AI chip demand, an aggressive antitrust investigation by Chinese regulators, and growing skepticism from industry leaders. The competition is intensifying, with Amazon developing its own Trainium AI chips, and Broadcom positioning itself to capture significant market share with custom AI chip solutions projected to reach $90 billion in the next three years. OpenAI co-founder Ilya Sutskever's stark statement that "we've achieved peak data" further undermines the narrative of unbridled AI growth.
The broader implications are profound and deeply concerning. Nvidia's struggles represent a microcosm of the larger technological ecosystem—a world where innovation is increasingly constrained by geopolitical tensions, regulatory challenges, and the harsh economic realities of diminishing returns. Despite massive capital expenditures by tech giants—with Microsoft nearly doubling its spending to $20 billion and Meta increasing expenses by 36%—only 4% of US workers use AI daily. This stark disconnect between investment and actual utility exposes the potential fragility of Nvidia's market position, with analysts suggesting that 2024 may have been the peak in terms of percentage increase for AI-related infrastructure spending.
Acquisitions
$CMGR Past hit $28 now .0035 7 Mil Float Tons of News and PRsImmense interest is still on this gem after moving 500%+ twice within the last month. It seems dilution has slowed down tremendously and it has found a bottom finally down here in the high .0030s to .0040s
I would anticipate another move is percolating and hopefully is sustained on a longer time scale, as it did in the past when it moved from .05 to $28 granted the float was probably closer to 1,000,000 back them, it being 7x that now we wont be seeing such an immense move but a $1+ move isn't out of the question given how easily it moves on news.
Its most recent 8K stated that GS Capital agreed to convert a convertible promissory, dated November 26, 2021, in the aggregate principal amount of $300,445 (the “Converted Note”), at the conversion price of $1.00
Which states there may very well be much more to come and to anticipate a much larger move on the horizon.
The company closed a promo deal with “The Farmers Dog, inc” raising a total funding of $103.1 Million
The company now has promo deals with Target, Dutch Bros. Coffee and Rob Gronkowski
In addition to several other recent deals inked.
SNY Fib Levels On The Radar & WhySNY and TBIO buttoned up the news this morning sending a bunch of other biotech stocks running higher. Now that this is out of the way, levels could be important for longs looking for "what's next" and the 236 Fib level seems to be that area to watch. It was an area that the volatile SNY stock settled above for weeks and now is an area it hasn't been able to break above for the last several weeks. Heading into the month after this acquisition, it's gonna be interesting to see if mRNA stocks start to catch a bit more.
" A mega buyout from Sanofi (NASDAQ: SNY) has investors looking at biotech stocks today. If you remember our article, “Top Biotech Penny Stocks On Robinhood To Watch This Week,” we discussed Sanofi and its strengthening relationship with a former penny stock, Translate Bio Inc. (NASDAQ: TBIO)...Sanofi had previously pledged to invest 400 million euros annually in a vaccines R&D facility to advance mRNA vaccines with Translate to benefit. Tuesday, Sanofi formally announced a $3.2 billion buyout of its vaccine collaboration partner. This was at $38 a share in cash, roughly 30% higher than the close on August 2nd. "
Quote Source & Read More: Hot Biotech Stocks To Watch After Sanofi’s Acquisition Of Translate Bio
$HWCC to be Acquired by OmniCable in $91 Million TransactionHouston Wire & Cable Company to be Acquired by OmniCable in $91 Million Transaction.
HWCC Stockholders to Receive $5.30 per Share in Cash
The transaction is expected to close following HWCC’s Annual Meeting of Stockholders, scheduled for May 25, 2021
finance.yahoo.com
$WIFI to be Acquired by Digital ColonyBoingo Wireless to be Acquired by Digital Colony
Boingo Shareholders to Receive $14.00 per share in Cash Transaction Valued at Approximately $854 Million.
Leading Digital Infrastructure Investment Firm, Digital Colony, Uniquely Positioned to Continue Investing in Boingo’s Diverse Network.
Boingo to Become a Privately Held Company Upon Completion of Transaction.
Digital Colony will acquire all the outstanding shares of Boingo common stock for $14.00 per share in cash through a merger, in a transaction valued at approximately $854 million, including the assumption of $199 million of Boingo’s net debt obligations. The acquisition price represents a 23% premium to Boingo’s closing price of $11.40 on February 26, 2021.
expected to close in the second quarter of 2021.
finance.yahoo.com
ICON to Acquire PRA Health Sciences, Creating a World LeaderICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research
The combined business will be no. 1 or 2 in key clinical market segments and have formal strategic partnerships with a majority of the top 20 biopharma companies, providing a platform for growth and innovation.
A cash and stock transaction valued at approximately $12 billion, with the per share merger consideration consisting of $80 in cash and 0.4125 shares of ICON stock. The consideration represents an approximately 30% premium to PRA’s closing price as of February 23rd, 2021.
The transaction is anticipated to be highly accretive delivering double-digit accretion in the first full year and growing to 20%+ thereafter, driven by growth momentum, estimated annual run-rate cost synergies of $150 million, and the combined effective tax rate decreasing to 14%, both to be realised in approximately 4 years.
finance.yahoo.com
Goodyear to Acquire $TCB Creating Stronger U.S.-Based LeaderGoodyear to Acquire Cooper, Creating Stronger U.S.-Based Leader in Global Tire Industry
Strengthens Leadership Position in Global Tire Industry
- Combines Two Complementary Brand Portfolios with a Comprehensive Offering Across the Value Spectrum
- Provides Significant, Immediate and Long-Term Financial Benefits
- Opportunity to Create Additional Value from Manufacturing and Distribution
- Increases Scale to Support Investments in New Mobility and Fleet Solutions
The transaction is expected to close in the second half of 2021.
finance.yahoo.com
$PGR Expand Commercial Lines Products with Acquisition of $PTVCBProgressive Expands Commercial Lines Products with Acquisition of Protective Insurance
Leader in Commercial Auto Insurance Seeks to Expand Capabilities
Protective Shareholders to Receive $23.30 Per Share in Cash
$PGR and $PTVCB today announced that they have entered into a definitive agreement under which Progressive has agreed to acquire all of the outstanding Class A and Class B common shares of Protective for $23.30 per share in cash, for a total transaction value of approximately $338 million.
The acquisition is expected to close prior to the end of the third quarter of 2021.
This move allows us to add products that will help us support larger fleets and brings expertise in workers’ compensation coverage for the transportation industry, which are new areas of business for us and can help us to meet the needs of our commercial customers.
finance.yahoo.com
$MGNI Surges on Its $1.17 Billion Deal for SpotX$MGNI Magnite to Acquire SpotX
Magnite (Nasdaq: MGNI), the largest independent sell-side advertising platform, today announced that it has entered into a definitive agreement to acquire SpotX from RTL Group for $1.17 billion in cash and stock. SpotX is one of the leading platforms shaping CTV and video advertising globally.
Deal Creates Largest Independent CTV & Video Advertising Platform
Full year 2020 combined company estimated non-GAAP net revenue would have been $350 million on a pro forma basis(1)(2)
Combined company Connected TV (CTV) & video net revenue would have represented approximately 67% of total company preliminary non-GAAP pro forma net revenue(1)(2) in Q4 2020
On a combined basis, the CTV business would have nearly tripled to $42 million in Q4 2020 versus Magnite standalone, or approximately 34% of Q4 2020 preliminary non-GAAP pro forma net revenue(1)(2)
The non-CTV video business of the combined company would have represented approximately 33% of Q4 2020 preliminary non-GAAP pro forma net revenue(1)(2)
SpotX total preliminary non-GAAP net revenue(1)(2) for 2020 was $116 million, of which $67 million was CTV
Purchase price consists of $560 million in cash and 14 million shares of Magnite stock, for a total of $1.17 billion based on the closing price of Magnite stock as of February 4, 2021
Magnite’s preliminary results for Q4 2020 include
GAAP Revenue of $82 million, up 69% on an as-reported basis, and up 20% on a pro forma basis from Q4 2019, with CTV revenue of $15.3 million, up 53% on a pro forma basis(1)
Net income of $5.8 million and Adjusted EBITDA(3) of $29.9 million, representing a 36% adjusted EBITDA margin(4)
Together, Magnite and SpotX will serve some of the world’s leading programmers, broadcasters, platforms and device manufacturers, including A+E Networks, Crackle Plus, The CW Network, Discovery, Disney/Hulu, Electronic Arts, Fox Corporation, fuboTV, Microsoft, Newsy, Philo TV, Pluto TV, Roku, Samsung, Sling TV, Tubi, ViacomCBS, Vizio, Vudu, WarnerMedia and Xumo.
finance.yahoo.com
Acquisition of Quellis Biosciences Inc.+private placementCatabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.
Acquisition Includes QLS-215, a Potential Best-in-Class Monoclonal Antibody Inhibitor of Plasma Kallikrein in Preclinical Development for the Treatment of Hereditary Angioedema
Concurrent with the acquisition of Quellis, Catabasis entered into a definitive agreement for the sale of Series X convertible preferred stock (the "Series X preferred stock") in a private placement to a group of institutional accredited investors.
Catabasis expects to use the proceeds from the private placement primarily to enable the completion of IND-enabling studies, Phase 1a, and Phase 1b/2 clinical trials for the lead program QLS-215 in hereditary angioedema (HAE), a rare, debilitating and potentially life-threatening disease.
Catabasis expects to file an Investigational New Drug application for QLS-215 in the first half of 2022 and plans to initiate a Phase 1 clinical trial with initial results anticipated by the end of 2022. Subsequently, Catabasis expects to initiate a Phase 1b/2 trial in patients affected by HAE in 2023 with initial results anticipated by the end of 2023.
About the Transactions
finance.yahoo.com
Atlantic Power Agrees to be Acquired by I Squared CapitalAtlantic Power Agrees to be Acquired by I Squared Capital
Common shareholders to receive US$3.03 per share in cash, representing a 48% premium to the 30-day volume weighted average price per common share on the NYSE
- Convertible debentures to be converted to common shares, including a make whole premium; following conversion, debenture holders will receive US$3.03 per share in cash
- Preferred shareholders and medium term noteholders to receive cash representing meaningful premiums to recent trading prices.
The total enterprise value of the deal is approximately US$961 million (based on current foreign exchange rates) and the transaction was unanimously approved by Atlantic Power's board of directors.
Atlantic Power's 6.00% Series E Convertible Unsecured Subordinated Debentures due January 31, 2025 will be converted into common shares of Atlantic Power immediately prior to the closing of the transaction based on the conversion ratio in effect at such time (including the "make whole premium shares" issuable under the terms of the trust indenture for the convertible debentures following a cash change of control).
Holders of the convertible debentures will receive US$3.03 per common share held following the conversion of the convertible debentures, plus accrued and unpaid interest on the convertible debentures up to, but excluding, the closing date of the transaction.
finance.yahoo.com
INAQ update - plot buys across the wicks on the trendlineBullish on INAQ and scaling in gradually to this SPAC under $14.
I like SPACs between $10 - 13 as there is very little downside but a lot of potential upside just before the ticker changes.
Looking at this chart my plan is to keep scaling in according to this wicks on the diagonal trendline which are like clockwork.
So next buy would be around 12.90 tomorrow - let's see if it pans out. I'm going to trade off this chart until the pattern changes, most likely that'll occur the closer we get to 13.5 which is the most significant local resistance.
Once INAQ breaks 13.5 I expect this to soar and be at $16 quite quickly. This can all be invalidated by a sell-off near that level or at the resistance. In that case, I will re-evaluate and look at support levels.
But classing this one as an 'investment' not a trade (until ticker changes over). Of course, do your own research and always know what type of trade you're taking before you enter in.
Sell Broadcom on this Symantec Acquisition, $20B Down The TubesBloomberg broke the news on Wednesday July 3rd, 2019 that Broadcom is in talks to buy struggling Symantec. This is a terrible idea on many fronts and $AVGO closed down 3% on the news. I believe that investors do not want this semiconductor company to waste $20 billion on a cybersecurity company (and why pick the one that seems to be struggling the most?). Certainly makes sense that we head lower over the next few days/weeks.
A few references:
AbbVie buying Allergan - stock closed down 15%
Salesforce buying Tableau - stock closed down 3% (but it hasn't dropped further)
$SODE Makes Headlines: Acquisitions and 50M Share Retirement$SODE just recently announced they acquired BitPlaza Inc., the worlds first bitcoin shopping center in the App Store. This is major news for SODE. This strategically couples to company to bitcoin and other blockchain related news. This is great as BTC recently has made a bullish run. Most analyst and investors believe this bullish run is going to continue its trend. As SODE 52 week highs have been upwards of .335 per share, off recent news, there is growing belief this company could be heavily undervalued.
APHRIA correction plus - over bad acquisitionAphria acquired a bad asset and is reported to be a shell company now. Down to pre-2017 prices and shown here compared to Canapy Growth, Tilray, Cronos (Aphria trying to acquire) and Aurora.
Watching for high $2 entry. Like watching GE go below $7. Bottom feeding.
$HIPH CEO Confirms Order Delivery to Start Next Week: CBD WaterThe CEO of $HIPH A Expansive High Growth MJ Stock with several acquisitions in the pipe and more to come, has announced that the deliveries for the CBD+Hydro Infused High PH Water will start delivery next week and explained the situation in a tweet earlier today:
"Wanted to provide an update, orders will be shipping out next week! Again apologies for delays, migrations issues, etc caused the initial delays, much smoother going forward, 3 weeks for delivery not acceptable. Thanks for everyone's patience! $HIPH"
The technicals of the chart also show triangular formations on the hourly going back a month in an upwards direction which confirms the uptrend.
Below are some of the major catalysts coming up for the MJ Sector as a whole:
Pending US Federal Hemp/CBD legalization DD/research links:
(1.)
The current Farm Act expires Sept 30th, 2018, legislators will attempt to pass a new Farm Act before the current Act expires, meaning; there's aprox. 99%+ certainty that the proposed US Federal Hemp/CBD legislation will be dealt with by congress in one way or the other on or before Sept 30th, 2018.
www.washingtonpost.com
The Hemp Farming Act of 2018 contains full spectrum legalization of Hemp & CBD on a US Federal level
en.wikipedia.org
It is easy to under-estimate the potential economic impact of US Federal Hemp/CBD legalization, but consider;
Hemp/CBD has been federally restricted for over 80 years.
en.wikipedia.org
Not only does CBD derived from Hemp have potential mass use on a national/federal level, but the Hemp by-products of CBD production have approximately 10,000 different additional uses:
www.bulkhempwarehouse.com
The US Federal legalization of Hemp/CBD is essentially a once-in-a-century event.
(2.)
On Oct. 17th Canada will experience full Marijuana legalization. This will also be another catalysts and full spectrum legalization of MJ in Canada puts pressure on the US to pass full spectrum legalization of Hemp/CBD for US Farmers to stand a chance of being able to compete with the Canadians in the massive international Hemp/CBD space.
(3.)
With 2018 being a mid-term election year; Cannabis stocks tend to out-perform when legalization is on the ballot, see the following 2 videos for further explanation:
pro.moneymappress.com
secure.caseyresearch.com
This November 6th these 4 states will vote to legalize Marijuana in different forms:
North Dakota: Recreational Marijuana.
Michigan: Recreational Marijuana.
Utah: Medical Marijuana.
Missouri: Medical Marijuana.
Next Leg up on $HIPH Confirmed Closing the Week Nicely GreenIt seems the market is finally realizing the full potential of CBD/Hemp products under the cornucopia that is $HIPH
The website which is being fully revamped and updated will be showing a line of products that may include other products from acquisitions $HIPH has already undertaken and brought into the company's fold and future acquisitions. The CEO Ryan Fishoff has been working dutifully to get the company up and running again, future uplistments to Pink Current then OTCQB along with several other product lines in store which will run into the CBD and Hemp niche markets.
I predict a very nice rebound here next week and possible new Highs as we head into the future updates and of course the impending MJ Rush later this year.
$MLTC 15-D Filed OTCMts Updated, Filings and Pink Current SoonMelt Inc. new CEO David Lazar filed a 15-D With $SHNL he filed this then all the Annual reports and the Attorney letter appeared on OTCMarkets the next day $RARS filed this and their filings and Attorney letter dropped 3 weeks later on OTCMarkets. He's however moving a lot faster here than he has with any of his other shells which is a good sign not to mention this:
Timeline Business Licenses:
***$MLTC***
Reinstated: 06/28/18
Expires: 07/31/19
$SHNL
Reinstated: 05/18/18
Expires: 06/30/19
$EQPI
Reinstated: 05/21/18
Expires: 03/31/19
$DRSX
Reinstated: 03/08/18
Expires: 11/30/18
$EENX
Reinstated: 4/17/18
Expires: 9/30/18
$OWVI
Reinstated: 05/01/18
Expires: 07/31/18
$RARS
Reinstated: 01/31/18
Expires: 06/30/18 (Already Expired)
LDSI awaiting filings - add the dipsWhen filings start hitting, this is giong to skyrocket. Big things in the works. Look at that accumulation.
$GRCV LT Play New CEO + A/S Reduction + Revenue/Profits/NetGainGrand Capital Ventures Inc. since the start of the year:
1. New CEO - Dr. Kyo Jhin
Florida-March 28, 2018 /RSS FEED -- Grand Capital Ventures Inc. (OTC PINK:GRCV) Dr. Kyo “Paul” Jhin has accepted the appointment to the position of CEO of Grand Capital Ventures Inc. The Company feels that Dr. Jhin’s proven dedication to excellence will launch the Company to tremendous heights. He brings a commitment to success that should help each of the Company’s subsidiaries to perform to their greatest potential and beyond.
Dr. Jhin is currently in the final stages of selecting an Executive Assistant to help him guide the Company and its subsidiaries.
Dr. Kyo “Paul” Jhin is the CEO of the eBook/eLibrary Initiative. The purpose of this Initiative is to send Laptops, Tablets and Smart Phones to schools in developing nations in Africa and South America.
1. President George W. Bush Appointment: Dr. Jhin was appointed as the Director of Peace Corps’ Special Initiatives, 2002-2009. In this position, Jhin was the Peace Corps’ liaison to the Department of State’s Inter-Agency Working Group, White House Initiative on Digital Freedom Initiative, and the United Nations Secretary General’s Office.
2. President George H. Bush Appointment: During 1990-1993, Dr. Jhin appointed to served as Executive Assistant to the Secretary of Veterans Affairs. Dr. Jhin's major responsibility was to launch Total Quality Management (TQM) initiatives in the agency and transform the VA to adopt TQM culture.
3. President Gerald Ford Appointment: 1976 – 1981, He was appointed as a Member of the National Advisory Council on Adult Education. In this position, he was one of the leaders to conduct hearings throughout the nation and he was selected to testify before the U.S. Congress.
2. Huge Acquisitions:
February 19, 2018
GRAND CAPITAL VENTURES INC COMPLETES ACQUISITION OF HOLLYWOOD FILM & ENTERTAINMENT COMPANY, EMPIRE MEDIA ENTERTAINMENT GROUP INC
backend.otcmarkets.com
MARCH 15, 2018
GRAND CAPITAL VENTURES INC ACQUIRES GALACTIC TECHNOLOGY INC.
backend.otcmarkets.com
www.galactictechnology.net
April 9, 2018
Grand Capital Ventures Inc. Announces Acquisition Of Track Killers Entertainment Inc & its Subsidiaries.
The World's First Digital Production Label
backend.otcmarkets.com
www.trackkillers.com
3. Year over Year Revenues/Profits and Net Gain
backend.otcmarkets.com
backend.otcmarkets.com
Q1 2017
Revenues: $26,250
Gross Profit: $26,250
Net Loss: -$9,956
Q1 2018
Revenues: $300,893
Gross Profit: $145,136
Net Profit: $95,635
4. Almost 890 million restricted shares have been retired in just 3 months + what was already retired upon taking over, which equates to be about 1.25 BILLION shares since his new BOD took over, thats OUTSTANDING, Not to mention that it was promised that AS was also going to be reduced proving they dont count on more dilution anytime soon.
5. Since the new BOD took over there has been many negotiations with long term friendly debt holders to restructure their debt and change them into preferred shares etc, in just a few months they have almost gotten rid of 600k in short term convertible debt of the $1 mil in total debt, this is a huge win for investors.